CUL4A functions as an oncogene in ovarian cancer and is directly regulated by miR-494

Xiaoni Han1, Ziling Fang2, Heng Wang3

  • 1Department of Obstetrics and Gynecology, The Fourth Affiliated Hospital of Nanchang University, Nanchang, 330003, Jiangxi Province, China.

Insights

Cullin 4A (CUL4A) is upregulated in ovarian cancer. MicroRNA-494 (miR-494) suppresses CUL4A, inhibiting tumor growth and metastasis, revealing a key miR-494/CUL4A axis in ovarian cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Cullin 4A (CUL4A) is an oncogene implicated in various cancers.
  • CUL4A is clinically upregulated in ovarian cancer, but its precise role and regulatory mechanisms remain unclear.

Purpose of the Study:

  • To elucidate the biological functions of CUL4A in ovarian cancer.
  • To identify the molecular mechanisms regulating CUL4A expression in ovarian cancer.
  • To investigate the potential role of microRNAs in CUL4A regulation.

Main Methods:

  • Quantitative analysis of CUL4A expression in ovarian cancer tissues versus non-cancerous tissues.
  • CUL4A gene silencing using small interfering RNA (siRNA).
  • Assessment of cell proliferation, invasion, and epithelial-mesenchymal transition (EMT) markers.
  • Identification of microRNA targets using molecular assays.
  • Overexpression of microRNA-494 (miR-494) and assessment of its effects on ovarian cancer cells.

Main Results:

  • CUL4A expression is significantly elevated in ovarian cancer tissues.
  • CUL4A silencing inhibits ovarian cancer cell proliferation, invasion, and EMT.
  • CUL4A is identified as a direct target gene of miR-494.
  • miR-494 is downregulated in ovarian cancer and correlates with poor prognosis.
  • miR-494 overexpression suppresses ovarian cancer cell proliferation, migration, invasion, and EMT by inhibiting CUL4A.

Conclusions:

  • The miR-494/CUL4A axis plays a critical role in regulating ovarian cancer tumorigenesis.
  • miR-494 functions as a tumor suppressor by targeting CUL4A.
  • This axis represents a potential therapeutic target for ovarian cancer treatment.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K